Enquiry/Quote
OnabotulinumtoxinA bulk supplier for pharma manufacturers

Onabotulinumtoxina Suppliers & Bulk Manufacturers

Available Forms: Injection

Available Strengths: 50 U, 100 U, 200 U

Reference Brands: Botox (USA/EU)

Category: Neurology

OnabotulinumtoxinA is a neurotoxic protein produced by Clostridium botulinum used for both therapeutic and cosmetic purposes. It works by blocking the release of acetylcholine at nerve endings, leading to temporary muscle relaxation. Marketed under the brand name Botox, it is available as a powder for injection in 50 U, 100 U, and 200 U vials. It is used to treat conditions like chronic migraine, muscle spasticity, cervical dystonia, overactive bladder, and for reducing facial wrinkles in cosmetic applications. OnabotulinumtoxinA is available in Injection and strengths such as 50 U, 100 U, 200 U. Sourced from GMP-certified and ISO-compliant manufacturers, this API meets global pharmacopeia standards (USP/EP/JP as applicable). Ideal for pharmaceutical formulation and commercial manufacturing, OnabotulinumtoxinA is supplied in bulk quantities with complete regulatory support including DMF, COA, and MSDS.

Technical Specifications & Supply Details
Lead Time 7 to 60 days (depending on batch size & schedule)
MOQ As per manufacturer’s batch size
COA Available with every batch
Regulatory Dossier / DMF Available upon request
Export Documentation FSC, COA, Manufacturing License, Product Permission
Standards IP, BP, USP
Certifications WHO-GMP, EU-GMP, USFDA (as applicable)

OnabotulinumtoxinA can be exported to over 30 countries across Asia, Africa, Europe, and Latin America. Flexible packaging, competitive pricing, and a verified supplier network make Pharmatradz a trusted sourcing partner for pharmaceutical companies and contract manufacturers worldwide.

Get Enquiry / Request Bulk Quote

Quick Response Guaranteed | Verified Suppliers

📘 Sourcing Guide

Product Description:

OnabotulinumtoxinA is a purified botulinum toxin type A used for both therapeutic and aesthetic applications. Marketed as Botox by Allergan (part of AbbVie), it is derived from the bacterium Clostridium botulinum and works by inhibiting the release of acetylcholine at the neuromuscular junction, leading to temporary muscle relaxation.

Clinically, OnabotulinumtoxinA is widely used to treat conditions such as severe underarm sweating (hyperhidrosis), cervical dystonia, and muscle spasms in the neck and shoulders. It is also commonly used in aesthetic medicine to reduce the appearance of facial wrinkles, including glabellar lines and crow’s feet. Additionally, it is being studied for potential use in managing pain associated with conditions like skin leiomyomas and other disorders.

The effects of treatment are localized and temporary, typically lasting for several months, after which repeat administration may be required. Manufactured under strict quality standards, OnabotulinumtoxinA offers a reliable and effective solution for both medical and cosmetic needs when administered by qualified healthcare professionals.

Disclaimer: By continuing to browse, you agree to the terms of use of this website and the Trade Marks displayed, in compliance with the provisions of the Trademark Act, 1999, Section 30 and 30(1) under 'Fair use.'

The Trade Mark owner has been correctly identified under the heading Manufacturer / TM Owner as required by the Act.
Back to Listing

Frequently Asked Questions

OnabotulinumtoxinA is used for both cosmetic and therapeutic purposes. It is commonly used to reduce facial wrinkles such as glabellar lines, forehead lines, and crow’s feet. It is also indicated for medical conditions including chronic migraine, cervical dystonia, muscle spasticity, overactive bladder, and hyperhidrosis.

OnabotulinumtoxinA is derived from botulinum toxin type A, a purified neurotoxic protein produced by the bacterium Clostridium botulinum. It works by blocking the release of acetylcholine at the neuromuscular junction.

The primary trade name is Botox.

OnabotulinumtoxinA is manufactured by Allergan, which is part of AbbVie.

The generic name is OnabotulinumtoxinA.

The brand name is Botox.

OnabotulinumtoxinA is manufactured in the United States and Europe by Allergan/AbbVie under strict regulatory standards and supplied globally.

Yes, OnabotulinumtoxinA is available with DMF and other regulatory documents such as COA and MSDS. These can be provided upon request for qualified buyers.

Absolutely. Sample requests are accepted for formulation trials and quality checks. Please submit an enquiry to initiate the process.

Our manufacturing partners are GMP-certified and comply with ISO and WHO standards, ensuring global quality benchmarks.

Lead times vary based on quantity and destination, but most orders are fulfilled within 1–3 weeks. Express shipping options are available.

Yes, OnabotulinumtoxinA is exported to over 30 countries across Asia, Africa, Europe, and Latin America. We support documentation for customs and regulatory clearance.

Related Products

Valproic Acid

Strength:
125 mg/mL, 200 mg, 250 mg, 300 mg, 500 mg, 100 mg/mL

Form: Tablet / Capsule/ Injection / Oral syrup

Reference Brands: Depakene (USA), Depakine (EU/LATAM), Valprol (India)

View Details
Ubrogepant

Strength:
50 mg, 100 mg

Form: Tablets

Reference Brands: Ubrelvy (USA/India)

View Details
Tolcapone

Strength:
100 mg

Form: Tablets

Reference Brands: Tasmar (USA/EU)

View Details
Safinamide

Strength:
50 mg ,100 mg

Form: Tablets

Reference Brands: Xadago (USA/EU)

View Details
Enquire Now

Quick Response Guaranteed | Verified Suppliers

Subscribe to Our Newsletter

Stay updated on pharma trends and marketplace opportunities.

Please enter the correct answer.
This website uses cookies to ensure you get the best experience. By using our site, you agree to our Privacy Policy.